An Animal Model of Hearing Loss From -Difluoromethylornithine
- 1 October 1989
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 115 (10) , 1234-1237
- https://doi.org/10.1001/archotol.1989.01860340088024
Abstract
• α-Difluoromethylornithine is a new antineoplastic and antiparasitic drug that inhibits the synthesis of polyamines. It causes a sensorineural hearing loss in humans. We have established an animal model for α-difluoromethylornithine-induced hearing loss. The time course for onset and recovery of the hearing loss in animals was similar to that seen in humans. Electrophysiologic and histologic data suggest that the anatomic site of α-difluoromethylornithine-induced hearing loss is the organ of Corti. Unlike other drugs with ototoxic effects, the specific enzymatic site of action of α-difluoromethylornithine is known, making it a potentially important tool in auditory research. (Arch Otolaryngol Head Neck Surg. 1989;115:1234-1237)This publication has 7 references indexed in Scilit:
- Inhibition of inner ear ornithine decarboxylase by neomycin in-vitroBrain Research Bulletin, 1987
- Clinical Aspects of Inhibition of Ornithine Decarboxylase with Emphasis on Therapeutic Trials of Eflornithine (DFMO) in Cancer and Protozoan DiseasesPublished by Elsevier ,1987
- Identification of polyamines in the cochlea of the rat and their potential role in hearingBrain Research Bulletin, 1986
- Phase I study of alpha-difluoromethylornithine and methyl-GAGEuropean Journal of Cancer and Clinical Oncology, 1986
- Organ of Corti surface preparations for computer-assisted morphometryHearing Research, 1986
- Chemotherapeutic implications of polyamine biosynthesis inhibitionClinical Pharmacology & Therapeutics, 1984
- Polyamines in Mammalian Biology and MedicinePerspectives in Biology and Medicine, 1979